EcoDrugPlus

Ptk2 Protein Tyrosine Kinase 2

Ensembl ID : ENSPEMG00000019854
Gene Symbol: PTK2
1 Cross references
326 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPEMG00000012385
Gene Symbol: PIM1
3 Cross references
244 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPEMG00000023829
Gene Symbol: PIM3
3 Cross references
217 Possible Orthologues:

Rar-Related Orphan Receptor Gamma

Ensembl ID : ENSPEMG00000019266
Gene Symbol: RORC
1 Cross references
382 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSPEMG00000021896
Gene Symbol: ROCK1
3 Cross references
215 Possible Orthologues:

Rho-Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSPEMG00000020257
Gene Symbol: ROCK2
1 Cross references
304 Possible Orthologues:

Ros1 Proto-Oncogene

Ensembl ID : ENSPEMG00000018962
Gene Symbol: ROS1
1 Cross references
124 Possible Orthologues:

Sem1, 26s Proteasome Complex Subunit

Ensembl ID : ENSPEMG00000023151
Gene Symbol: SEM1
1 Cross references
155 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSPEMG00000020092
Gene Symbol: SRC
3 Cross references
262 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSPEMG00000000588
Gene Symbol: TEK
3 Cross references
164 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSPEMG00000020411
Gene Symbol: TTK
1 Cross references
203 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSPEMG00000023666
Gene Symbol: UGCG
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).